Literature DB >> 26997353

Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints.

Ilya Lipkovich1, Bohdana Ratitch2, Michael O'Kelly3.   

Abstract

Over the past years, significant progress has been made in developing statistically rigorous methods to implement clinically interpretable sensitivity analyses for assumptions about the missingness mechanism in clinical trials for continuous and (to a lesser extent) for binary or categorical endpoints. Studies with time-to-event outcomes have received much less attention. However, such studies can be similarly challenged with respect to the robustness and integrity of primary analysis conclusions when a substantial number of subjects withdraw from treatment prematurely prior to experiencing an event of interest. We discuss how the methods that are widely used for primary analyses of time-to-event outcomes could be extended in a clinically meaningful and interpretable way to stress-test the assumption of ignorable censoring. We focus on a 'tipping point' approach, the objective of which is to postulate sensitivity parameters with a clear clinical interpretation and to identify a setting of these parameters unfavorable enough towards the experimental treatment to nullify a conclusion that was favorable to that treatment. Robustness of primary analysis results can then be assessed based on clinical plausibility of the scenario represented by the tipping point. We study several approaches for conducting such analyses based on multiple imputation using parametric, semi-parametric, and non-parametric imputation models and evaluate their operating characteristics via simulation. We argue that these methods are valuable tools for sensitivity analyses of time-to-event data and conclude that the method based on piecewise exponential imputation model of survival has some advantages over other methods studied here.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Keywords:  delta adjustment; multiple imputation; sensitivity analysis; time-to-event analysis; tipping point analysis

Mesh:

Year:  2016        PMID: 26997353     DOI: 10.1002/pst.1738

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  7 in total

1.  Using Synthetic Data to Replace Linkage Derived Elements: A Case Study.

Authors:  Dean M Resnick; Christine S Cox; Lisa B Mirel
Journal:  Health Serv Outcomes Res Methodol       Date:  2021-02-03

2.  SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale.

Authors:  Shu Yang; Yilong Zhang; Guanghan Frank Liu; Qian Guan
Journal:  Biometrics       Date:  2021-08-27       Impact factor: 2.571

3.  Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.

Authors:  David M Kent; Jeffrey L Saver; Scott E Kasner; Jason Nelson; John D Carroll; Gilles Chatellier; Geneviève Derumeaux; Anthony J Furlan; Howard C Herrmann; Peter Jüni; Jong S Kim; Benjamin Koethe; Pil Hyung Lee; Benedicte Lefebvre; Heinrich P Mattle; Bernhard Meier; Mark Reisman; Richard W Smalling; Lars Soendergaard; Jae-Kwan Song; Jean-Louis Mas; David E Thaler
Journal:  JAMA       Date:  2021-12-14       Impact factor: 157.335

4.  Reference-based sensitivity analysis for time-to-event data.

Authors:  Andrew Atkinson; Michael G Kenward; Tim Clayton; James R Carpenter
Journal:  Pharm Stat       Date:  2019-07-15       Impact factor: 1.894

Review 5.  A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data.

Authors:  Ping-Tee Tan; Suzie Cro; Eleanor Van Vogt; Matyas Szigeti; Victoria R Cornelius
Journal:  BMC Med Res Methodol       Date:  2021-04-15       Impact factor: 4.615

6.  Impute the missing data using retrieved dropouts.

Authors:  Shuai Wang; Haoyan Hu
Journal:  BMC Med Res Methodol       Date:  2022-03-27       Impact factor: 4.615

7.  A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.

Authors:  Suzie Cro; Tim P Morris; Brennan C Kahan; Victoria R Cornelius; James R Carpenter
Journal:  BMC Med Res Methodol       Date:  2020-08-12       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.